【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
T-Cell Leukemia Overview 8
Therapeutics Development 9
Pipeline Products for T-Cell Leukemia – Overview 9
Pipeline Products for T-Cell Leukemia – Comparative Analysis 10
T-Cell Leukemia – Therapeutics under Development by Companies 11
T-Cell Leukemia – Therapeutics under Investigation by Universities/Institutes 12
T-Cell Leukemia – Pipeline Products Glance 13
Clinical Stage Products 13
Early Stage Products 14
T-Cell Leukemia – Products under Development by Companies 15
T-Cell Leukemia – Products under Investigation by Universities/Institutes 16
T-Cell Leukemia – Companies Involved in Therapeutics Development 17
Applied Immune Technologies Ltd 17
Astellas Pharma Inc. 18
Bristol-Myers Squibb Company 19
Celgene Corporation 20
iDD biotech SAS 21
Kyowa Hakko Kirin Co., Ltd. 22
MediGene AG 23
Nippon Kayaku Co., Ltd. 24
Pfizer Inc. 25
Pharmacyclics, Inc. 26
Sanofi 27
Stemline Therapeutics, Inc. 28
Theravectys S.A. 29
Tolero Pharmaceuticals, Inc. 30
T-Cell Leukemia – Therapeutics Assessment 31
Assessment by Monotherapy Products 31
Assessment by Target 32
Assessment by Mechanism of Action 34
Assessment by Route of Administration 36
Assessment by Molecule Type 38
Drug Profiles 40
AGS-67E – Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
alemtuzumab – Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
Antibody to Inhibit HLA-A2 for Neurology, Infectious Diseases and T-Cell Leukemia – Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
BMS-906024 – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
Cell Therapy to Target CD38 for cancer – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
IDD-003 – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
INA-01 – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
lenalidomide – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
MMIG-202 – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
mogamulizumab – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
Monoclonal Antibodies to Antagonize TCR for Leukemia and Autoimmune Disease – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
Monoclonal Antibody to Target CCR9 for T Lymphoblastic Leukemia – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
NK-314 – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
Oncolytic Virus to Target Glycoprotein gp160 for T-cell Leukemia – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
PCI-34051 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
PF-03084014 – Drug Profile 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
SL-101 – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
Synthetic Peptide for Oncology and Male health – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
THV-02 – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
TP-0903 – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
T-Cell Leukemia – Recent Pipeline Updates 68
T-Cell Leukemia – Dormant Projects 85
T-Cell Leukemia – Discontinued Products 86
T-Cell Leukemia – Product Development Milestones 87
Featured News & Press Releases 87
Feb 04, 2015: THERAVECTYS Obtains Orphan Drug Designation from the European Medicines Agency for Its Lentiviral Vector-Based Therapeutic Vaccine against Adult T-Cell Leukemia and Lymphoma 87
Dec 18, 2014: Approval for Additional Indication for Chemotherapy-Native CCR4-positive ATL of Mogamulizumab 88
Sep 29, 2014: Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study 88
Aug 23, 2012: Kyowa Hakko Kirin Initiates Pivotal Phase II Trial Of Mogamulizumab In Patients With Adult T-cell Leukemia-Lymphoma In US And Europe 89
Jul 19, 2012: Application Seeking Approval for Additional Indication for ATL, PTCL and CTCL of Mogamulizumab 89
May 29, 2012: Kyowa Hakko Kirin Launches POTELIGEO Injection In Japan 90
Jan 25, 2012: Study Shows Leukemia Drug Kills Cancerous T-cells While Sparing Normal Immunity 90
Dec 07, 2010: Kyowa Hakko Kirin Announces Results From Japan Phase II Clinical Trial Of KW-0761 In Adult T-Cell Leukemia-Lymphoma 91
Appendix 92
Methodology 92
Coverage 92
Secondary Research 92
Primary Research 92
Expert Panel Validation 92
Contact Us 92
Disclaimer 93
【レポート販売概要】
■ タイトル：T細胞白血病(T-Cell Leukemia)：治療薬開発パイプライン動向（2015年上半期版）■ 英文：T-Cell Leukemia - Pipeline Review, H1 2015
■ 発行日：2015年2月24日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6280IDB
■ 調査対象地域：グローバル
- 肥満：現在及び未来の競争環境分析PharmaPoint: Obesity - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Obesity - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing obesity market. The report identifies and analyses the key companies shaping and driving the global obesity market. The report p …
- 磁気抵抗RAM（MRAM）の世界市場分析：タイプ別（トグル、スピントランスファトルク）、用途別（消費者家電、ロボット工学、自動車、企業用ストレージ、航空宇宙）、地域別、セグメント予測、2014-2025The global magneto resistive RAM (MRAM) market is expected to reach USD 4.80 billion by 2025, according to a new study by Grand View Research, Inc. Non-volatile memories, such as MRAM and Resistive random Access Memory (RRAM/ReRAM), are expected to replace the existing volatile memories such as Dynamic Random Access Memory (DRAM) and Static Random-Access Memory (static RAM or SRAM). The replacemen …
- 小型原子力発電炉の分析：Analyzing Small Nuclear Power ReactorsThe global energy jigsaw is constantly and increasingly being rearranged with the nuclear power supply. Nuclear power is increasingly presenting an alternative to become the mainstay of energy needs for the new society till the time developments are further underway for cleaner energy sources. The harnessing of this energy would not have been possible without the inventing effort of Le? Szil?rd in …
- 超伝導体の世界市場2019-2023About this market The increased adoption of superconductor devices in medical applications is the key factors driving the global superconductor market growth. Many medical devices such as MRI imaging devices are integrated with HTS cables and superconducting magnets to generate high magnetic fields. Therefore, several manufacturers are focusing on advances in superconducting technologies to improv …
- オートバイADAS（先進運転支援システム）の世界市場：ABS、ACC、TCS、その他Global Motorcycle Advanced Driver Assistance System (ADAS) Market: About this market Motorcycle advanced driver assistance system (ADAS) is specifically designed with a safe human-machine interface, which helps in enhancing the safety of the rider and the motorcycle. Technavio’s motorcycle advanced driver assistance system (ADAS) market analysis considers sales from segments including ABS, ACC, TC …
- 世界のデジタルカメラ市場動向To maximize product differentiation, smartphone brands have been upgrading their camera modules for improved photo quality. Their efforts in advancing smartphone photography, however, have jeopardized the global digital camera market. This is especially detrimental to the survival of entry-level and mid-range digital cameras. For this reason, digital camera brands have been repositioning their pro …
- 米国の移動補助・運搬機器市場見通し（～2021）United States Mobility Aids and Transportation Equipment Market Outlook to 2021 Summary GlobalData’s new report, "United States Mobility Aids and Transportation Equipment Market Outlook to 2021", provides key market data on the United States Mobility Aids and Transportation Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dolla …
- 世界の構造化データ管理ソフトウェア市場：リレーショナルデータベース管理システム（RDMS）、 データ統合/アクセスソフトウェア等About Structured Data Management Software Structured data management software is used to store and manage various forms of data generated by companies. It is also an approach to manage the flow of data through the entire cycle (from creation of the data to the time it is deleted) in organizations. Recently, the need for the effective management of corporate data has increased widely due to growing …
- 世界における膵臓癌検査製品のパイプライン動向2015Pancreatic Cancer - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Pancreatic Cancer - Pipeline Review, 2015" provides an overview of Pancreatic Cancer diagnostic tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major pl …
- 医療レポート：Non-Small Cell Lung Cancer (NSCLC)-疫学予測（～2022）EpiCast Report: Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2022 Summary Lung cancer is a disease of uncontrolled cell growth in the lung tissues. It is one of the most commonly occurring cancers in the world, representing almost 13% of all cancers (Ferlay et al., 2010). NSCLC is the most common type of lung cancer, comprising about 85% of all lung cancers. An estimated 1.37 mill …
- ワイヤレスオーディオ製品の世界市場：サウンドバー、スピーカー、ヘッドホン、ヘッドセットThe market for wireless audio is expected to reach USD 54.07 Billion by 2022, at a CAGR of 23.2% between 2016 and 2022. This market is primarily driven by the growth of the market for smartphones, which are used as a source of entertainment, rise in the adoption of portable devices, high expenditure on R&D for wireless audio technology by OEMs, advancements in technologies, and growing demand for …
- 世界のクロマトグラフィー・システム市場：Global Chromatography Systems Market 2014-2018TechNavio's analysts forecast the Global Chromatography Systems market to grow at a CAGR of 5.66 percent over the period 2013-2018. One of the key factors contributing to this market growth is the advancement in technology. The Global Chromatography Systems market has also been witnessing the increasing outsourcing of pharmaceutical production to the APAC region. However, the high cost could pose …
- 世界のクラッシュバリヤー（ガードレール）装置市場2015The Global Crash Barrier Systems Industry Report 2015 is a professional and in-depth study on the current state of the Crash Barrier Systems industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Crash Barrier Systems market analysis is provided for the international markets including development trends, …
- 世界の鼻腔内薬物送達市場及び開発パイプラインIntranasal drug delivery has evolved in the recent years as a significant method of delivering drugs through the nasal route. This method has been identified to have all the potential to achieve significant milestones in the pharmaceutical industry, as it is largely driven by its capability to cure local infections and chronic allergies. The human nose, which has a unique vascular structure, makes …
- 血栓性血小板減少性紫斑(Thrombotic Thrombocytopenic Purpura)：治療薬開発パイプライン動向（2015年上半期版）Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2015’, provides an overview of the Thrombotic Thrombocytopenic Purpura’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Thrombotic Thrombocytopenic Purpura, complete with comparative analy …
